-
AAP: Denying transplants to kids with intellectual, developmental disabilities…
Chelsea Adams Medical & Allied HealthcareThe American Academy of Pediatrics (AAP) released a policy statement in April that says physicians who deny organs to children with intellectual and developmental disabilities may be acting in a discriminatory manner. "Patients should not be excluded from consideration for solid organ transplant solely on the basis of an intellectual or developmental disability," the guidance states. The policy statement's authors, Dr. Mindy B. Statter and Dr. Garey Noritz, also write that "children without disabilities have no more claims to scarce resources, such as organ transplants, than do children with disabilities."
-
President Trump signs Paycheck Protection Program 2.0
Seth Sandronsky Business Management, Services & Risk ManagementOn April 24, President Trump signed a second Paycheck Protection Program (PPP) of $484 billion to aid an economy that is shrinking sharply from the COVID-19 pandemic. In the past 35 days, as leisure, hospitality and retail businesses have closed across the U.S., over 24 million workers have filed claims for unemployment insurance. According to the president’s Twitter account, PPP 2.0 includes $310 billion to replenish the small business PPP, $75 billion for hospitals and $25 billion for COVID-19 tests.
-
As CMS delays interoperability and transparency rules, study suggests they’re…
Scott E. Rupp Medical & Allied HealthcareThe Trump administration is pausing its previously established deadlines for the healthcare industry to come into compliance with rules prohibiting information blocking and the rule that mandates interoperability. These decisions are the result of health systems currently being overwhelmed by the COVID-19 pandemic sweeping the globe. However, interoperability and enhanced information sharing are improving overall healthcare quality, safety, and costs for U.S. patients and providers, a new Surescripts 2019 National Progress Report points out.
-
Infographic: Wound care in the age of coronavirus
Brian Wallace Medical & Allied HealthcareWe are only months into the COVID-19 pandemic. With no clear end in sight, the serious effects of delaying wound care need to be addressed in a strategic way. The innovative solutions we create today will not only ensure continuous and compassionate care now but will also permanently shape the future of care delivery. This infographic outlines the migration to tech solutions like telehealth and what that means for something as crucial as wound care during the pandemic.
-
Podcast: How to spark innovation to keep your practice thriving well beyond…
Jarod Carter Healthcare AdministrationAt a time when most business owners are scrambling to keep their business alive in a pandemic and reaching for any low-hanging fruit they can manage, it’s those that get truly innovative and creative that will not only survive the pandemic but also become the strongest companies long term. So, I couldn’t think of a better time for this episode with Duncan Wardle, the former VP of innovation and creativity for Disney.
-
Translating the COVID-19 information firehose as a healthcare professional
Keith Carlson Medical & Allied HealthcareIn these days of the COVID-19 pandemic, many of us find ourselves wondering what evidence-based information we should follow and what news sources to avoid. We may first choose to do this simply to keep ourselves sane and focused amidst the noise so that we can function as both private citizens and healthcare professionals. Having said that, we are also likely to feel the heavy responsibility of skillfully curating information so that we can translate the firehose of pandemic-related information for our loved ones who turn to us for reassurance, education, and clarity. In this regard, where do we begin?
-
Prevention and treatment of COVID-19 with hydroxychloroquine (PATCH) trial
Dorothy L. Tengler Medical & Allied HealthcareHydroxychloroquine (HCQ), or Plaquenil, is used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine and is also used to treat autoimmune diseases such as rheumatoid arthritis, lupus, and porphyria cutanea tarda. Importantly, as recently reported in the Journal of the American Medical Association, there is no high-quality evidence demonstrating efficacy of HCQ or its chemical cousin, chloroquine, to treat COVID-19. Consequently, a new trial (NCT04329923), led by researchers at the University of Pennsylvania, will test whether HCQ can treat or prevent COVID-19.
-
Healthcare’s furloughs continue even as parts of the US begin to…
Scott E. Rupp Healthcare AdministrationThe cratering of the healthcare job market has continued as COVID-19 spreads across the United States. In all sectors, more than 22 million people have filed for unemployment benefits as of April 17, with the virus, for now, wiping out a decade of job gains. The United States has not seen this level of job loss since the Great Depression. Healthcare, long seen as an untouchable career field — safe from the ups and downs of the economy — is among the sectors hardest hit by the pandemic.
-
Infographic: The promise of digital therapeutics
Brian Wallace Science & TechnologyBy 2025, the market for digital therapeutics is expected to reach $7.8 billion. This infographic outlines various technologies in this field, such as video games to treat multiple sclerosis and autism, apps for addiction treatment, and even ultrasound tech to treat Parkinson's.
-
Associations face a new advocacy landscape
Jeb Ory Association ManagementAs many people in Washington know, the COVID-19 crisis launched an advocacy boom. What they may not realize is that it is far from over. As Congress considered a $2 trillion stimulus bill — the largest in U.S. history — hundreds of organizations scrambled to ensure that lawmakers understood and addressed their needs, whether that meant safety equipment, financial support, tax relief or other necessities. Trade associations led that charge.
All Healthcare Administration Articles